Related references
Note: Only part of the references are listed.The role of endoscopic endonasal surgery in the management of prolactinomas based on their invasiveness into the cavernous sinus
Hussam Abou-Al-Shaar et al.
PITUITARY (2022)
Determinants of Surgical Remission in Prolactinomas: A Systematic Review and Meta-Analysis
Kyla Wright et al.
WORLD NEUROSURGERY (2021)
Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis
Amir H. Zamanipoor Najafabadi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
An Effective and Practical Fluid Restriction Protocol to Decrease the Risk of Hyponatremia and Readmissions After Transsphenoidal Surgery
Dina Winograd et al.
NEUROSURGERY (2020)
Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery
Grzegorz Zielinski et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Predictors of the Response to Dopaminergic Therapy in Patients With Prolactinoma
Camille Hage et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Dopamine Agonist-Induced Impulse Control Disorders in Patients With Prolactinoma: A Cross-Sectional Multicenter Study
Sema Ciftci Dogansen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new
Philippe Chanson et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
A practical method for prevention of readmission for symptomatic hyponatremia following transsphenoidal surgery
William T. Burke et al.
PITUITARY (2018)
Optimal timing of dopamine agonist withdrawal in patients with hyperprolactinemia: a systematic review and meta-analysis
Miao Yun Xia et al.
ENDOCRINE (2018)
Cost-Effectiveness Analysis of Surgical versus Medical Treatment of Prolactinomas
Corinna C. Zygourakis et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2017)
Surgical treatment for male prolactinoma A retrospective study of 184 cases
Yi-Jun Song et al.
MEDICINE (2017)
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
Felipe F. Casanueva et al.
PITUITARY (2017)
SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP
Diane Donegan et al.
ENDOCRINE PRACTICE (2017)
Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases
Safak Akin et al.
ACTA NEUROCHIRURGICA (2016)
THERAPY OF ENDOCRINE DISEASE Surgery in microprolactinomas: effectiveness and risks based on contemporary literature
Metaxia Tampourlou et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Management of medically refractory prolactinoma
Mark E. Molitch
JOURNAL OF NEURO-ONCOLOGY (2014)
Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients
Alessandro Paluzzi et al.
PITUITARY (2014)
Prospective Trial of a Short Hospital Stay Protocol After Endoscopic Endonasal Pituitary Adenoma Surgery
Jonathan G. Thomas et al.
WORLD NEUROSURGERY (2014)
Surgical treatment of prolactinomas: cons
Eve Bloomgarden et al.
ENDOCRINE (2014)
Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients
Vanessa Primeau et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Dopamine agonists and the risk of cardiac-valve regurgitation
Rene Schade et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
Renzo Zanettini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Advances in the treatment of prolactinomas
Mary P. Gillam et al.
ENDOCRINE REVIEWS (2006)
The prevalence of pituitary adenomas - A systematic review
S Ezzat et al.
CANCER (2004)
Share Paper
